128 related articles for article (PubMed ID: 38442699)
1. Multifocal Insulinoma as the Unique Presenting Feature of MEN1 in an Adolescent.
Murray A; Rodas Marquez SP; Krishnamurthy M; Lopez-Nunez O; Gurria JP; Trout AT; Almazan S; Mutyala K; Shah A; Howell J
Horm Res Paediatr; 2024 Mar; ():. PubMed ID: 38442699
[TBL] [Abstract][Full Text] [Related]
2. Expression of transcription factors in MEN1-associated pancreatic neuroendocrine tumors.
Takeda Y; Fujita Y; Sakai K; Abe T; Nakamura T; Yanagimachi T; Sakagami H; Honjo J; Abiko A; Makino Y; Haneda M
Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28924486
[TBL] [Abstract][Full Text] [Related]
3. Multifocal pancreatic PPoma in the setting of MEN1: Case report and review of literature.
Mosenia A; Ward C; Yee A; Qorbani A; Corvera C
Int J Surg Case Rep; 2021 Jun; 83():106008. PubMed ID: 34118524
[TBL] [Abstract][Full Text] [Related]
4. GHRH secretion from a pancreatic neuroendocrine tumor causing gigantism in a patient with MEN1.
Srirangam Nadhamuni V; Iacovazzo D; Evanson J; Sahdev A; Trouillas J; McAndrew L; R Kurzawinski T; Bryant D; Hussain K; Bhattacharya S; Korbonits M
Endocrinol Diabetes Metab Case Rep; 2021 Jun; 2021():. PubMed ID: 34156350
[TBL] [Abstract][Full Text] [Related]
5. Synchronous Solid Pseudopapillary Tumor and Insulinoma in an Adolescent MEN1 Patient Presenting with Diagnostic Dilemmas.
Uçar A; Özgüven B; Battal M; Alparslan Pınarlı F; Özmen E; Yetim A; Yılmaz Y
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(4):375-379. PubMed ID: 28663159
[TBL] [Abstract][Full Text] [Related]
6. Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).
Lastoria S; Marciello F; Faggiano A; Aloj L; Caracò C; Aurilio M; D'Ambrosio L; Di Gennaro F; Ramundo V; Camera L; De Luca L; Fonti R; Napolitano V; Colao A
Endocrine; 2016 Jun; 52(3):488-94. PubMed ID: 26242621
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of Multiple Pancreatic Neuroendocrine Tumors Identified by 68Ga-DOTANOC and 68Ga-exendin-4 PET/CT in a Patient with Endogenous Hyperinsulinemic Hypoglycemia and Multiple Endocrine Neoplasia 1.
Xu J; Xu X; Zhang M; Liu W; Chen J; Song S
Neuroendocrinology; 2024 Mar; ():. PubMed ID: 38471465
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1.
Jhawar S; Lakhotia R; Suzuki M; Welch J; Agarwal SK; Sharretts J; Merino M; Ahlman M; Blau JE; Simonds WF; Del Rivero J
Endocrinol Diabetes Metab Case Rep; 2019 Aug; 2019():. PubMed ID: 31480016
[TBL] [Abstract][Full Text] [Related]
9. New therapies for patients with multiple endocrine neoplasia type 1.
Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
[TBL] [Abstract][Full Text] [Related]
10. Insulinoma in childhood: a retrospective review of 22 patients from one referral centre.
Melikyan M; Gubaeva D; Shadrina A; Bolmasova A; Kareva M; Tiulpakov A; Efremenkov A; Sokolov Y; Brusgaard K; Christesen HT; Andersen K; Stepanov A; Averyanova J; Makarov S; Gurevich L
Front Endocrinol (Lausanne); 2023; 14():1127173. PubMed ID: 37152923
[TBL] [Abstract][Full Text] [Related]
11. Long delay in diagnosis of a case with MEN1 due to concomitant presence of AIMAH with insulinoma: a case report and literature review.
Chavoshi V; Tamehri Zadeh SS; Khalili S; Rabbani A; Matini SAH; Mohsenifar Z; Hadaegh F
BMC Endocr Disord; 2022 Apr; 22(1):108. PubMed ID: 35448982
[TBL] [Abstract][Full Text] [Related]
12. Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China.
Zhao Y; Yu J; Liu Y; Lyu L; Ping F; Xu L; Li W; Wang O; Xu Q; Wu W; Zhang H; Li Y
Orphanet J Rare Dis; 2022 Jun; 17(1):219. PubMed ID: 35698198
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
[TBL] [Abstract][Full Text] [Related]
14. Metastatic Grade 3 Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Expressing Somatostatin Receptors.
Graf A; Welch J; Bansal R; Mandl A; Parekh VI; Cochran C; Levy E; Nilubol N; Patel D; Sadowski S; Jha S; Agarwal SK; Millo C; Blau JE; Simonds WF; Weinstein LS; Del Rivero J
J Endocr Soc; 2022 Oct; 6(10):bvac122. PubMed ID: 36111275
[TBL] [Abstract][Full Text] [Related]
15. [Multicentric insulinoma associated with multiple endocrine neoplasia type 1: One case report].
Gamboa-Jiménez TI; Juárez-Aguilar FG
Rev Med Inst Mex Seguro Soc; 2018 Oct; 56(3):316-319. PubMed ID: 30394721
[TBL] [Abstract][Full Text] [Related]
16. Late onset asymptomatic pancreatic neuroendocrine tumor - A case report on the phenotypic expansion for MEN1.
Kaiwar C; Macklin SK; Gass JM; Jackson J; Klee EW; Hines SL; Stauffer JA; Atwal PS
Hered Cancer Clin Pract; 2017; 15():10. PubMed ID: 28736585
[TBL] [Abstract][Full Text] [Related]
17. 68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report.
Liu Y; Zhao X; Zhang J; Wang J; Zhang Z; Dai M; Wang N; Jing F; Wang T; Tian W
Medicine (Baltimore); 2022 Aug; 101(34):e30252. PubMed ID: 36042606
[TBL] [Abstract][Full Text] [Related]
18. Co-existence of glucagonoma with recurrent insulinoma in a patient with multiple endocrine neoplasia-type 1 (MEN-1).
Nishiuchi T; Imachi H; Murao K; Fujiwara M; Muraoka T; Kikuchi F; Nishiuchi Y; Kushida Y; Haba R; Ishida T
Endocrine; 2009 Aug; 36(1):20-4. PubMed ID: 19350420
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
